RIP kinase Overview
| Cat No. | Product Name | CAS No. | Purity | Order |
|---|---|---|---|---|
| I026698 | Eclitasertib | 2125450-76-0 | 98.0% | Inquiry |
| I022334 | Apostatin-1 | 98.0% | Inquiry | |
| I019986 | Nec-4 | 1041644-43-2 | ≥ 95% | Inquiry |
| I019551 | GSK963 | 2049868-46-2 | ≥ 95% | Inquiry |
| I019595 | HS-1371 | 2158197-70-5 | ≥ 95% | Inquiry |
| I019282 | GSK840 | 2361146-30-5 | ≥ 95% | Inquiry |
| I019295 | cRIPGBM | 2361988-76-1 | ≥ 95% | Inquiry |
| I019304 | GSK2593074A | 1337531-06-2 | ≥ 95% | Inquiry |
| I019199 | GSK547 | 2226735-55-1 | ≥ 95% | Inquiry |
| I019224 | GSK3145095 | 1622849-43-7 | ≥ 95% | Inquiry |
| I019087 | RIP2 Kinase Inhibitor 3 | 1398053-50-3 | ≥ 95% | Inquiry |
| I019038 | RIPK1-IN-7 | 2300982-44-7 | ≥ 95% | Inquiry |
| I018664 | PK68 | 2173556-69-7 | ≥ 95% | Inquiry |
| I018681 | RIPK1-IN-3 | 2242677-36-5 | ≥ 95% | Inquiry |
| I018498 | RIP1 kinase inhibitor 1 | 2095515-38-9 | ≥ 95% | Inquiry |
| I018511 | RIPK-IN-4 | 2141969-56-2 | ≥ 95% | Inquiry |
| I018276 | RIPK1-IN-4 | 1481641-08-0 | ≥ 95% | Inquiry |
| I017900 | GSK2983559 free acid | 1579965-12-0 | ≥ 95% | Inquiry |
| I015153 | RIPK3-IN-1 | 2361139-70-8 | ≥ 95% | Inquiry |
| I013923 | Necrostatin 2 racemate | 852391-15-2 | ≥ 95% | Inquiry |
| I013765 | GSK583 | 1346547-00-9 | ≥ 95% | Inquiry |
| I013767 | GSK(acute)481 | 1622849-58-4 | ≥ 95% | Inquiry |
| I013224 | GSK(acute)872 | 1346546-69-7 | ≥ 95% | Inquiry |
| I012597 | GSK/'843 | 1601496-05-2 | ≥ 95% | Inquiry |
| I011913 | GSK/'872 | 1346546-69-7 | ≥ 95% | Inquiry |